TVTX
Travere Therapeutics Inc
NASDAQ: TVTX · HEALTHCARE · BIOTECHNOLOGY
$40.10
-1.93% today
Updated 2026-04-29
Market cap
$3.70B
P/E ratio
—
P/S ratio
7.55x
EPS (TTM)
$-0.57
Dividend yield
—
52W range
$14 – $43
Volume
1.9M
Travere Therapeutics Inc (TVTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-689.00 | $-49.00 | $-2.74M | $-17.59M | $-45.85M | $-554000.00 | $-1.60M | $7.40M | $-24.96M | $-58.21M | $-42.74M | $-14.79M | $-186.29M | $-280.02M | $-237.47M | $37.78M |
| Capital expenditures | $0.00 | $0.00 | $1.19M | $5.55M | $3.96M | $7.03M | $11.92M | $14.01M | $19.70M | $15.56M | $119.84M | $24.15M | $28.37M | $41.59M | $101.21M | $58.16M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $17.56M | $1.42M | $15.90M | $25.90M | $29.10M | $26.87M | $19.77M | $21.11M | $23.61M | $29.57M | $38.14M | $44.25M | $36.91M | $44.87M |
| Free cash flow | $-689.00 | $-49.00 | $-3.93M | $-23.14M | $-49.81M | $-7.58M | $-13.52M | $-6.61M | $-44.66M | $-73.78M | $-162.59M | $-38.94M | $-214.66M | $-321.61M | $-338.69M | $-20.37M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $93.69M | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | $23.64M | $79.27M | $-101.27M | — | — | — |